
Venture investor backing food and beverage technology companies, run by finance professionals and former food operators
Los Angeles investment adviser managing long/short portfolios of biotechnology and medical device stocks

DAFNA Capital Management is an SEC-registered investment adviser in Los Angeles. It manages long/short portfolios made up mostly of publicly traded biotechnology and medical device companies. The firm was founded in 1999.
Investors who entrust the firm with their wealth. The managers say most of their own wealth is invested alongside clients.
Summary written by TrustList from the business's own published information, Oct 2026.
Dafna Capital Management is ranked on 1 TrustList ranking at #3.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Dafna Capital Management has no reviews yet and 2 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is one of 3 here listing medical and one of 4 here listing biotechnology.
Its profile: “DAFNA Capital Management is an SEC-registered investment adviser in Los Angeles.”
Of the top 58 here, 10 also cover partners and 9 also cover growth stage; 20 also work in New York City and 9 also work in San Francisco.
Behind Shamrock Capital Advisors, ahead of Angeleno Group.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Dafna Capital Management.
Similar listings buyers compare against this one.

Venture investor backing food and beverage technology companies, run by finance professionals and former food operators

A life sciences venture fund investing in biotechnology and biopharma companies across multiple stages

Corporate venture arm of Northwestern Mutual investing in financial, health and analytics technology, plus a Wisconsin startup fund

Miami-based venture fund and startup studio for early-stage real estate and construction technology companies

Bank offering personal and business banking, lending, treasury services and wealth management

Impact investor and accelerator backing early tech startups in emerging markets and underserved communities

Life science investor putting money into young oncology and genetic disease drug developers

Australian venture capital fund investing only in startups with measurable social and environmental impact
Everything here links back to the same verified catalogue. Pick your next stop.